Eli Lilly and Company (LLY)

Last Closing Price: 883.33 (2024-06-13)

Consolidated Net Income/Loss (Quarterly)

Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.

Eli Lilly and Company (LLY) had Consolidated Net Income/Loss of $2.24B for the most recently reported fiscal quarter, ending 2024-03-31.

Figures for fiscal quarter ending 2024-03-31
Income Statement Financials
$8.77B
$2.24B
$1.67B
$7.09B
$6.26B
$2.51B
$27.10M
$2.54B
$2.54B
$2.24B
$2.24B
Consolidated Net Income/Loss
$2.24B
$2.24B
$2.51B
$2.91B
900.80M
903.80M
$2.49
$2.48
Balance Sheet Financials
$25.19B
$13.62B
$38.75B
$63.94B
$18.60B
$24.56B
$32.45B
$51.05B
$12.90B
$1.20B
$12.90B
950.40M
Cash Flow Statement Financials
$1.17B
$-1.18B
$-311.30M
$2.82B
$2.46B
$-358.40M
$159.40M
$-1.17B
--
Fundamental Metrics & Ratios
1.35
--
--
0.66
2.03
80.91%
28.62%
28.62%
--
28.92%
25.58%
$179.70M
--
--
--
0.14
0.27
0.88
102.78
17.39%
187.60%
3.51%
5.99%
$13.57
$0.20
$1.29